![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, July 28, 2020 3:41:35 PM
I have doubts this is DCVax. Does anyone here know for sure?
biosectinvestor,
I know for sure that it is NOT DCVax-L!
IOZK (Cologne in Germany) is the private clinic of Prof.Stefaan Van Gool.
Last year Laura Nuttall started her immunotherapy treatment at the IOZK clinic under Professor Van Gool.
In late October 2018, Laura got the bad news that she had GBM. (Unmethylated- IDH wild type - multiple brain tumours, i believe there were 9)
As it’s #EyeWeek just wanted to thank @bootsopticians @westfieldlondon who back in October spotted pressure behind Laura’s eyes which on further investigation showed multiple brain tumours. A quick diagnosis can make all the difference @HeadSmartUK @BrainTumourOrg pic.twitter.com/kSRw86gISw
— shitscaredmum (@shitscaredmum) September 26, 2019
The DCVax-L treatment was not an option for technical (tumour related) reasons.
Laura is doing pretty well at the moment!
March 10, 2019 by Nicola Nuttall.
So here we are, 4 months after surgery and 2 months into the 12 cycles of chemotherapy we have scheduled......
In terms of treatment, the monthly chemo is hitting her pretty hard but the recent scan does suggest that she may be responding to the treatment which is great news. We're having lots of conversations with the DCVax people and hopefully it won't be too long before we can update you with further news in that area.
May 8, 2019 by Nicola Nuttall.
Yesterday marks 6 month's since Laura's surgery and although some days are rubbish and she's sick and exhausted, other days are amazing.
.......
The DCVax treatment process started but it's had to be put on hold for technical (tumour related) reasons.
We are hoping that soon we'll be in a position to start the process again but in the meantime we're continuing to explore further immunotherapy treatments available internationally.
July 30, 2019
More excitingly, Laura and I are currently in Cologne where we have just started immunotherapy treatment at the IOZK clinic under Professor Van Gool.
This treatment starts with electrohyperthermia treatment and the Introduction of an oncolytic virus to help her immune system to recognise and identify the tumour cells.
We will be returning to Cologne for 5 days every month whilst Laura is still on chemo and when that ends she will return for further sessions where she will receive the dendritic cell vaccine, manufactured from her reprogrammed white blood cells.
Obviously we have no guarantees but we’re optimistic that this is the best course of action for her.
DECEMBER 30, 2019
So looking to the future, Laura has her final round of chemo in January and from February she’ll start the Dendritic cell vaccination protocol in Cologne, she’ll be having her next scan in January too which is always a bit nerve wracking for us.
Without you, we wouldn’t have been able to start the immunotherapy treatment in Germany and for that and for your continued support and love, we are truly grateful
MAY 1, 2020
I am pleased to say that Laura is doing pretty well at the moment, her last scan was in March and although it's still showing a 4mm 'spot' it is at least stable at the moment.
https://www.gofundme.com/f/ngdq37-doing-it-for-laura
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM